FAST BIOPHARMA
Fast BioPharma Ltd. develops therapeutic products for treatment of cancer.
FAST BIOPHARMA
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2016-01-01
Status:
Active
Similar Organizations
Auration Biotech
Auration Biotech develops therapeutics for the treatment of ear, nose, and throat diseases.
CAVU Medical
CAVU Medical develops a restrictive device for the treatment of obesity.
Max Planck Institute for Experimental Cardiology
Max Planck Institute for Heart and Lung Research is a healthcare provider for the treatment of heart disease.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Oxford Vacmedix
Develop therapeutic agents for the treatment of cancer .
Pansend Life Sciences, LLC
Pansend, LLC develops products to treat osteoarthritis of the knee
Prima Biomed
Prima BioMed is a globally active leader in the development of personalized immunocellular therapeutic products for the treatment of cancer.
Therinject
Therinject is a pharmaceutical company focused on developing therapeutics for the treatment of cancer.
Vaxira
Vaxira is a therapeutic vaccine for the treatment of non-small cell lung cancer
More informations about "Fast BioPharma"
Fast BioPharma - Crunchbase Company Profile & Funding
Fast BioPharma is located in Oxford, Oxfordshire, United Kingdom. Who are Fast BioPharma 's competitors? Alternatives and possible competitors to Fast BioPharma may include Novita …See details»
People - FasT Biopharma
In 2016 Peter cofounded and became CEO of FasT Biopharma. David Blakey, Ph.D., Chief Scientific Officer. David Blakey has over 30 years of drug development expertise in both big Pharma and small Biotech. He has a …See details»
FAST BIOPHARMA LTD - LinkedIn
FAST BIOPHARMA LTD | 108 followers on LinkedIn. Unleashing the immune system to defeat cancer | FAST BIOPHARMA LTD is a company based in Aston Rowant, Oxfordshire, UKSee details»
FasT Biopharma Company Profile | Management and Employees …
FasT Biopharma Profile and History. FasT Biopharma Ltd was established in 2016 to address new targets in immuno-oncology (IO). We are funded by Alderley Park Ventures and we are …See details»
Pipeline - FasT Biopharma
FasT Biopharma is addressing multiple FasL-dependent diseases with high medical need. Each programme is based on a unique highly-potent anti-FasL antibody, designed and engineered …See details»
FasT Biopharma - PitchBook
FasT Biopharma General Information Description. Developer of therapeutic antibodies designed to address new targets in immuno-oncology. The company's antibodies target different types of solid and hematological tumors, enabling …See details»
FAST BIOPHARMA LTD Company Profile - Dun & Bradstreet
Fast biopharma ltd. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / watlington …See details»
FasT Biopharma - Company Profile - Tracxn
Feb 24, 2025 FasT Biopharma is involved in the development of an optimized antibody for immuno-oncology. The compnay flagship product is targeting the inhibitory mechanisms which …See details»
FAST BIOPHARMA LTD overview - Find and update company …
People for FAST BIOPHARMA LTD (09981769) More for FAST BIOPHARMA LTD (09981769) Registered office address 10 Aston Park, Aston Rowant, Watlington, Oxfordshire, United …See details»
Fast BioPharma Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Fast BioPharma Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Biological products ...See details»
FasT Biopharma - Products, Competitors, Financials, Employees ...
FasT Biopharma specializes in the development of candidate therapeutics in the biopharmaceutical industry. Use the CB Insights Platform to explore FasT Biopharma's full …See details»
FasT Biopharma | BIO-Europe Spring - Informa Connect
Fast Biopharma, a UK company based in Oxford and Alderley Park, seeks to address the failure of checkpoint inhibitor therapy in the majority of cancer patients by targeting T-cell death. Fas …See details»
FBP003 - Drug Targets, Indications, Patents - Synapse
FBP003, Initially developed by Fast BioPharma Ltd., Now, its global highest R&D status is Preclinical, Active Org.: Fast BioPharma Ltd.. Biomedical products. Data. Feature. Plans. Sign …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»
Fast BioPharma Ltd. - BioCentury Company Profiles - BCIQ
Fast BioPharma Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Fast BioPharma - Crunchbase
Organization. Fast BioPharma . Connect to CRM . Save . Summary People Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. Companies like Fast …See details»
The most innovative biotech companies of 2025 - Fast Company
Mar 18, 2025 Estimated revenue doubled from $4M in 2023 to $8 million in 2024, and biopharma partnerships increased from 3 to 8. 9. IO Biotech ... Explore the full 2025 list of Fast …See details»
FasT Biopharma - Overview, News & Similar companies - ZoomInfo
Who is FasT Biopharma. FasT Biopharma Ltd was established in 2016 to address new targets in immuno-oncology (IO). We are funded by Alderley Park Ventures and we are based in …See details»
USE OF HUMAN PRIMARY CELLS FOR DISCOVERY OF NOVEL …
Fast Biopharma Ltd aims to provide innovative experimental therapeutics for the treatment of cancer. The current focus is on using the natural immune response to fight tumours. Recent …See details»
FBP001 - Drug Targets, Indications, Patents - Synapse - Patsnap
FBP001, Initially developed by Fast BioPharma Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Eye Diseases, Active Indication: Glaucoma, Active Org.: Fast …See details»